Medicare Enrolled

Dr. May Azem, MD

Rheumatology · Concord Twp, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
7527 FREDLE DR, Concord Twp, OH 44077
4407090055
In practice since 2007 (18 years)
NPI: 1407049133 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Azem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azem? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Azem

Dr. May Azem is a rheumatology specialist in Concord Twp, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Azem performed 72,361 Medicare services across 980 unique beneficiaries.

Between the years covered by Open Payments, Dr. Azem received a total of $83,071 from 52 pharmaceutical and/or device companies across 1295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Azem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 7% volume in OH $83,071 industry payments

Medicare Practice Summary

Medicare Utilization ↗
72,361
Medicare services
Top 7% in OH for rheumatology
980
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,020 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
34,050 $11 $40
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
20,254 $26 $140
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
9,250 $34 $100
Denosumab injection (Prolia/Xgeva) 4,620 $18 $30
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
1,141 $21 $150
Hymovis intra-articular injection
An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space.
888 $13 $44
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
767 $86 $280
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
733 $95 $400
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
199 $53 $180
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
150 $124 $360
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
63 $27 $100
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
59 $1 $25
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
57 $4 $25
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
55 $11 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $60 $180
New patient office visit, complex (60-74 min) 24 $156 $450
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $36 $115
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $116 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
88.8% high complexity
9.8% medium
1.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$83,071
Total received (2018-2024)
Avg $11,867/year across 7 years
Top 9% in OH for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,295
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$41,393 (49.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,776 (29.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,902 (20.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,050
2023
$5,045
2022
$5,038
2021
$11,159
2020
$15,917
2019
$23,108
2018
$17,754

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,018
ABBVIE INC.
$743
Janssen Biotech, Inc.
$691
UCB, Inc.
$607
ANI Pharmaceuticals, Inc.
$418
PFIZER INC.
$349
Novartis Pharmaceuticals Corporation
$311
E.R. Squibb & Sons, L.L.C.
$176
Mallinckrodt Hospital Products Inc.
$138
Lilly USA, LLC
$127
Organon Llc
$80
Alexion Pharmaceuticals, Inc.
$50
Radius Health, Inc.
$45
GlaxoSmithKline, LLC.
$45
SOBI, INC
$45
Genentech USA, Inc.
$44
AstraZeneca Pharmaceuticals LP
$41
Azurity Pharmaceuticals, Inc.
$41
Aurinia Pharma U.S., Inc.
$23
Sandoz Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Kyowa Kirin, Inc.
$18
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$41,847
Janssen Biotech, Inc.
$7,763
Mallinckrodt LLC
$5,559
NOVARTIS PHARMACEUTICALS CORPORATION
$5,047
Amgen Inc.
$4,217
UCB, Inc.
$2,684
Novartis Pharmaceuticals Corporation
$2,338
PFIZER INC.
$1,658
Genentech USA, Inc.
$1,638
AbbVie Inc.
$1,379
Horizon Therapeutics plc
$1,038
ABBVIE INC.
$920
Mallinckrodt Hospital Products Inc.
$823
ANI Pharmaceuticals, Inc.
$784
E.R. Squibb & Sons, L.L.C.
$720
GlaxoSmithKline, LLC.
$571
AbbVie, Inc.
$330
AstraZeneca Pharmaceuticals LP
$328
Radius Health, Inc.
$320
Regeneron Healthcare Solutions, Inc.
$317
Celgene Corporation
$277
Antares Pharma, Inc.
$242
Ultragenyx Pharmaceutical Inc.
$208
Alexion Pharmaceuticals, Inc.
$203
Exeltis, USA Inc.
$160
Mallinckrodt Enterprises LLC
$150
Organon LLC
$140
ARBOR PHARMACEUTICALS, INC.
$129
GENZYME CORPORATION
$127
Rigel Pharmaceuticals, Inc.
$122
MEDEXUS PHARMA, INC.
$98
Janssen Scientific Affairs, LLC
$96
SOBI, INC
$88
Arbor Pharmaceuticals, Inc.
$82
Organon Llc
$80
Sandoz Inc.
$78
Actelion Pharmaceuticals US, Inc.
$74
Azurity Pharmaceuticals, Inc.
$59
IBSA Pharma Inc.
$56
Merck Sharp & Dohme Corporation
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$31
FIDIA PHARMA USA INC.
$26
Horizon Pharma plc
$25
Fresenius Kabi USA, LLC
$25
Flexion Therapeutics, Inc.
$24
Aurinia Pharma U.S., Inc.
$23
Fidia Pharma USA Inc.
$21
Kyowa Kirin, Inc.
$18
Mylan Institutional Inc.
$15
Pacira Therapeutics, Inc.
$15
MEDAC PHARMA, INC.
$14
Top 3 companies account for 66.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CUVITRU · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · HADLIMA · HORIZANT · HUMIRA · HYMOVIS · HYRIMOZ · Horizant · Hulio · Humira · Hymovis · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LICART · LUPKYNIS · LYRICA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OLUMIANT · OMVOH · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavalisse · Tavneos · Tirosint · Tymlos · ULTOMIRIS · UPLIZNA · UPTRAVI · VELSIPITY · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for rheumatology in OH.

Looking for a rheumatology specialist in Concord Twp?
Compare rheumatologists in the Concord Twp area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
20
Per 100K population
8.6
County median income
$77,952
Nearest hospital
LAKE HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Azem is a mixed practice specialist, with above-average Medicare volume (top 7% in OH), with speaking/promotional industry engagement in the top 9% of OH peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Azem experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Azem performed 34,050 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Azem receive payments from pharmaceutical companies?
Yes. Dr. Azem received a total of $83,071 from 52 companies across 1,295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azem's costs compare to other rheumatologists in Concord Twp?
Dr. Azem's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →